How big is the U.S. hematology diagnostics market?

The U.S. hematology diagnostics market size was estimated at USD 2.12 billion in 2023 and is expected to reach USD 2.25 billion in 2024.

What is the U.S. hematology diagnostics market growth?

The U.S. hematology diagnostics market is expected to grow at a compound annual growth rate (CAGR) of 5.3% over the forecast period 2024 to 2030 to reach USD 3.07 billion by 2030.

Which segment accounted for the largest U.S. hematology diagnostics market share?

The consumables segment accounted for the largest market share of around 65% in 2023 and is expected to grow at the fastest CAGR of 5.4% over the forecast period. The increasing prevalence of hematological disorders and the adoption of advanced diagnostic technologies are driving the demand for consumables products in the U.S. hematology diagnostics market.

Who are the key players in the U.S. hematology diagnostics market?

Some of the key companies operating in the U.S. hematology diagnostics market include Beckman Coulter Diagnostics; Siemens Healthineers, Mindray Medical International Limited; and F. Hoffmann-La Roche Ltd., Sysmex Corporation; Beckman Coulter, Inc.; and HORIBA, Ltd.

What are the factors driving the U.S. hematology diagnostics market?

The market growth is attributed to factors such as the rising prevalence of hematological disorders due to aging populations and changing lifestyles necessitating increased diagnostic testing. Technological advancements like flow cytometry, PCR, and NGS enhance diagnostic accuracy and efficiency, driving adoption.